University nets $40M for cancer research
Yale Daily News Wed, 30 Mar 2011 06:02 AM PDT
A $40 million gift to the Yale School of Medicine will support research and clinical infrastructure for genetic treatments of cancer. |
News Briefs
Israel National News Wed, 30 Mar 2011 06:00 AM PDT
Dr. Doron "Shalom" Avital (Kadima) has been sworn into the Knesset to replace Member of Knesset Z'ev Boim, who recently passed away from cancer. The 52-year old Avital, a lieutenant-colonel in reserves, led the elite Sayeret Matkal unit between the years 1992-1994. |
Amgen, Takeda drug fails advanced lung-cancer study
Reuters Wed, 30 Mar 2011 05:57 AM PDT
NEW YORK (Reuters) - Amgen Inc and Takeda Pharmaceutical Co Ltd said their experimental drug, motesanib, had failed to improve overall survival in a late-stage study of patients with advanced lung cancer. |
Basket raffle items for fundraiser for former Maple Shade business owner with cancer being collected now
Maple Shade Progress Wed, 30 Mar 2011 05:56 AM PDT
Roxie Forcella, owner of Flowers from Heaven, which was located on Main Street, has been diagnosed with Leukemia, a cancer of the blood and bone marrow and Lymphoma, a cancer of the lymphatic system. Her husband Bob, who was recently laid off, has been taking care of her, but without insurance and both being out of work, the medical bills are piling up, friends said. |
Amgen cancer drug fails in late-stage study
INO News Wed, 30 Mar 2011 05:53 AM PDT
(AP:NEW YORK) Amgen Inc. and Takeda Pharmaceutical Company Ltd. said Wednesday that their potential cancer treatment motesanib failed to meet its key goal in a late-stage study focusing on lung cancer patients. |
Donation will make cancer journey a little easier
North Platte Telegraph Wed, 30 Mar 2011 05:50 AM PDT
The North Platte Telegraph Hearing the word "cancer" from someone within your circle of friends and family is a life-altering experience. It only takes a visit to the annual Relay for Life ceremony to understand just how much cancer impacts this community. |
Nuke crisis reignites debate on protective pills
9 News Denver Wed, 30 Mar 2011 05:46 AM PDT
WASHINGTON (AP) - The Japanese nuclear crisis has reignited a debate in the U.S. over the government's role in distributing a cheap anti-cancer drug to people living around nuclear power plants. |
Expression Analysis Announces Recipients of Its Annual GWAS and Data Analysis Grant Co-Sponsored by Illumina
Business Wire Wed, 30 Mar 2011 05:46 AM PDT
DURHAM, N.C.--(BUSINESS WIRE)--EA today announced this year’s recipients of its annual GWAS and Data Analysis grant: Elad Ziv from the University of California, San Francisco (UCSF) and Chunyan He from Indiana University School of Medicine (IUSM). The grant was co-sponsored by Illumina and selection of the recipients was made by an outside review panel and facilitated by the American Cancer ... |
Yale and Gilead Sciences Announce Cancer Research Collaboration
Business Wire Wed, 30 Mar 2011 05:45 AM PDT
FOSTER CITY, Calif. & NEW HAVEN, Conn.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) and Yale School of Medicine today announced the formation of a multi-year research collaboration focused on the discovery of novel cancer therapies. The research effort will initially span four years with an option to renew for up to ten years. Gilead will provide $40 million in research support and ... |
| |
|